ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

Annual Report to the Nation Shows Decline In Overall Cancer Death Rates

January 11, 2013